{"gene":"NR2C1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1995,"finding":"NR2C1 (TR2 orphan receptor) binds hormone response elements (HREs) consisting of AGGTCA half-site direct repeats with binding affinity in the order DR1 > DR2 > DR5 ≈ DR4 ≈ DR6 > DR3, and also binds palindromic TREpal and NBRE elements. It competes with RXRα and RARα/RXRα heterodimers for binding to CRBPIIp (DR1) and RARΕβ (DR5) response elements, suppressing their transcriptional activation. This suppression is not mediated by heterodimer formation with RXRα or RARα, but rather by higher affinity (≥100-fold) of NR2C1 for CRBPIIp compared to RXRα.","method":"Gel mobility shift assays for HRE binding; CAT reporter assays for transcriptional competition; binding affinity measurements","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CAT reporter assays and gel-shift assays in single lab with two orthogonal methods","pmids":["8530418"],"is_preprint":false},{"year":1998,"finding":"Mouse NR2C1 (TR2-11) functions as a transcriptional repressor via mechanisms requiring: (1) high-affinity DNA binding, (2) receptor dimerization, and (3) an active silencing domain encoded within the DEF (ligand-binding) segment. Point mutations at three conserved leucine residues on the predicted dimer interface abolish suppressive activity, dimerization, and DNA binding. Mutation of two consecutive glutamate residues in the hinge between helices 10–11 of the LBD abolishes suppressive activity and DNA binding without affecting dimerization, demonstrating that dimerization can be uncoupled from suppressive activity. The C-terminal 49 amino acids are required for trans-suppressive activity as shown by GAL4 chimera assays.","method":"CAT reporter assays, point mutagenesis of dimer interface and LBD residues, GAL4-chimera transcriptional assays, deletion analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods including mutagenesis, deletion analysis, and chimeric reporter assays defining functional domains","pmids":["9660764"],"is_preprint":false},{"year":1999,"finding":"The mouse NR2C1 (TR2-11) gene promoter contains a functional IR0-type retinoic acid response element (5'-GGGTCA CGAACT-3') in its proximal promoter. RARα/RXRβ heterodimers bind specifically to this IR0 element (Kd ~8 nM) in gel retardation assays; neither receptor alone binds efficiently. This element drives RA-inducible reporter expression in COS-1 cells with exogenous RARα/RXRβ, and in P19 cells with endogenous receptors, establishing a cross-regulatory loop between NR2C1 and the RAR/RXR pathway.","method":"Gel mobility shift assays, Kd determination, CAT/reporter assays in COS-1 and P19 cells, nuclear extract binding assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution-like binding with Kd measurement plus functional reporter assays in two cell systems with orthogonal methods","pmids":["10393558"],"is_preprint":false},{"year":2000,"finding":"The mouse NR2C1 (TR2-11) gene promoter minimal activity is defined within 212 nucleotides upstream of the translation start site, and efficient promoter activity requires splicing of intron 1. RARα/RXRβ binding to this minimal promoter region was demonstrated by gel retardation assays. In P19 cells, the endogenous NR2C1 gene is induced by retinoic acid in a protein synthesis-independent manner. Overexpression of NR2C1 protein in P19 cells results in cellular apoptosis in the absence of RA.","method":"Reporter/promoter-deletion assays, gel retardation assays, protein synthesis inhibition (cycloheximide) experiments, overexpression in P19 cells with apoptosis readout","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple assays in single lab including gel retardation, reporter assays, and functional overexpression with apoptosis phenotype","pmids":["10807954"],"is_preprint":false},{"year":2016,"finding":"NR2C1 modulates transcriptional activity of pluripotency regulators Oct4 and Nanog, and affects promoter activity of Pepck (a differentiation proxy) and embryonic stem cell colony size (self-renewal proxy). Human, chimpanzee, and ancestral NR2C1 variants show functional differences in these assays, indicating that amino acid changes in NR2C1 during hominid evolution altered its ability to regulate pluripotency and cell lineage commitment.","method":"Luciferase reporter assays for Oct4, Nanog, and Pepck promoters; embryonic stem cell colony size assays; comparison of human, chimpanzee, and ancestral NR2C1 variants","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays and stem cell colony assays with multiple NR2C1 variants in single study","pmids":["27075724"],"is_preprint":false},{"year":2017,"finding":"Nr2c1 (Tr2) is required for early retinal cell patterning; loss of Nr2c1 causes severe vision deficit and disrupts early (but not late) retinal cell types, with increased displaced amacrine cells and disrupted cone cell topography. ChIP experiments reveal NR2C1 directly binds regulatory regions of transcription factors controlling retinal progenitor cells, including Satb2 (amacrine regulator) and thyroid and retinoic acid receptors (cone photoreceptor regulators).","method":"Nr2c1 knockout mouse (loss-of-function), histological and cell-type analysis, chromatin immunoprecipitation (ChIP) assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with specific cellular phenotype plus ChIP establishing direct chromatin binding to target gene regulators","pmids":["28551284"],"is_preprint":false}],"current_model":"NR2C1 (TR2/TR2-11) is an orphan nuclear receptor that functions primarily as a transcriptional repressor by binding DR-type hormone response elements as a homodimer, competing with RAR/RXR heterodimers for DNA occupancy, and silencing target genes through an active repression domain in its ligand-binding region (DEF segment); it is itself transcriptionally induced by retinoic acid via an IR0-type RARE in its promoter bound by RARα/RXRβ heterodimers, participates in regulating stem cell pluripotency (Oct4/Nanog), and is required in vivo for early retinal cell fate determination by directly binding chromatin at genes controlling progenitor cell identity."},"narrative":{"mechanistic_narrative":"NR2C1 (TR2/TR2-11) is an orphan nuclear receptor that acts as a sequence-specific transcriptional repressor controlling cell fate decisions and the retinoid signaling axis [PMID:8530418, PMID:28551284]. It binds AGGTCA half-site direct-repeat hormone response elements with a preference order of DR1 > DR2 > DR5 ≈ DR4 ≈ DR6 > DR3, as well as palindromic TREpal and NBRE elements, and it antagonizes RXRα and RARα/RXRα by outcompeting them for shared elements such as CRBPIIp (DR1) and RARβ (DR5) — a competition driven by NR2C1's ≥100-fold higher DNA affinity rather than by heterodimerization [PMID:8530418]. Repression requires three separable activities: high-affinity DNA binding, receptor dimerization through a leucine-dependent dimer interface, and an active silencing domain within the C-terminal DEF (ligand-binding) region, whose terminal 49 residues confer trans-suppression in GAL4 chimeras [PMID:9660764]. NR2C1 is itself embedded in a cross-regulatory loop with the retinoid pathway: its proximal promoter contains an IR0-type RARE bound by RARα/RXRβ heterodimers (Kd ~8 nM), rendering the gene retinoic-acid-inducible in a protein-synthesis-independent manner [PMID:10393558, PMID:10807954]. Functionally, NR2C1 modulates the pluripotency regulators Oct4 and Nanog and influences embryonic stem cell self-renewal and lineage commitment [PMID:27075724], and it is required in vivo for early retinal cell patterning, binding chromatin at regulators of progenitor identity including Satb2 and thyroid/retinoic acid receptors, with its loss causing vision deficits and disrupted amacrine and cone cell organization [PMID:28551284].","teleology":[{"year":1995,"claim":"Established that NR2C1 is a DNA-binding orphan receptor that represses retinoid target genes not by heterodimerizing with RXR/RAR but by directly outcompeting them at shared response elements.","evidence":"Gel mobility shift and CAT reporter competition assays with affinity measurements on CRBPIIp and RARβ elements","pmids":["8530418"],"confidence":"Medium","gaps":["Repression mechanism downstream of DNA occupancy not defined","No cofactor or chromatin-modifying partner identified","Endogenous target genes not yet mapped"]},{"year":1998,"claim":"Dissected the repression machinery into separable modules, showing dimerization can be uncoupled from suppression and localizing an active silencing domain to the C-terminal DEF region.","evidence":"Point mutagenesis of dimer-interface leucines and LBD glutamates, deletion analysis, and GAL4-chimera assays","pmids":["9660764"],"confidence":"High","gaps":["Corepressor proteins recruited by the silencing domain not identified","No structural model of the dimer interface or LBD","Ligand, if any, for the orphan LBD unknown"]},{"year":1999,"claim":"Defined a feedback loop placing NR2C1 downstream of retinoid signaling via an IR0-type RARE in its own promoter bound by RARα/RXRβ.","evidence":"Gel retardation with Kd determination and reporter assays in COS-1 and P19 cells","pmids":["10393558"],"confidence":"High","gaps":["Physiological significance of the autoregulatory loop in vivo not tested","Other promoter inputs not characterized"]},{"year":2000,"claim":"Refined the minimal promoter and showed RA induction is protein-synthesis-independent, while implicating NR2C1 in cell survival when overexpressed.","evidence":"Promoter-deletion reporter assays, cycloheximide experiments, and overexpression with apoptosis readout in P19 cells","pmids":["10807954"],"confidence":"Medium","gaps":["Mechanism linking NR2C1 overexpression to apoptosis unresolved","Requirement for intron 1 splicing mechanistically unexplained"]},{"year":2016,"claim":"Linked NR2C1 to control of pluripotency and lineage commitment, and showed hominid sequence changes altered its regulatory output.","evidence":"Luciferase reporter assays on Oct4, Nanog, and Pepck promoters and ES cell colony assays comparing human, chimpanzee, and ancestral variants","pmids":["27075724"],"confidence":"Medium","gaps":["Direct chromatin binding at Oct4/Nanog loci not demonstrated","In vivo developmental consequence of variant differences untested"]},{"year":2017,"claim":"Demonstrated an in vivo developmental requirement, with NR2C1 directly binding regulators of retinal progenitor identity to control early cell-fate patterning.","evidence":"Nr2c1 knockout mouse with histological cell-type analysis and ChIP at Satb2 and thyroid/retinoic acid receptor loci","pmids":["28551284"],"confidence":"High","gaps":["Whether NR2C1 activates or represses each retinal target not resolved","Cofactors mediating retinal target regulation unknown","Genome-wide binding landscape not defined"]},{"year":null,"claim":"Whether NR2C1 has an endogenous ligand and which corepressor complexes execute its DEF-domain silencing remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No ligand identified for the orphan LBD","Corepressor/chromatin-modifier partners of the silencing domain not identified","No structural data on DNA-bound NR2C1"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,5]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,4,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,5]}],"complexes":[],"partners":["RARA","RXRB","RXRA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P13056","full_name":"Nuclear receptor subfamily 2 group C member 1","aliases":["Orphan nuclear receptor TR2","Testicular receptor 2"],"length_aa":603,"mass_kda":67.3,"function":"Orphan nuclear receptor. Binds the IR7 element in the promoter of its own gene in an autoregulatory negative feedback mechanism. Primarily repressor of a broad range of genes. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Together with NR2C2, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription. Also activator of OCT4 gene expression. May be involved in stem cell proliferation and differentiation. Mediator of retinoic acid-regulated preadipocyte proliferation","subcellular_location":"Nucleus; Nucleus, PML body","url":"https://www.uniprot.org/uniprotkb/P13056/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NR2C1","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NR2C1","total_profiled":1310},"omim":[{"mim_id":"617962","title":"ZINC FINGER PROTEIN 827; ZNF827","url":"https://www.omim.org/entry/617962"},{"mim_id":"602490","title":"NUCLEAR RECEPTOR-INTERACTING PROTEIN 1; NRIP1","url":"https://www.omim.org/entry/602490"},{"mim_id":"601529","title":"NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1; NR2C1","url":"https://www.omim.org/entry/601529"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cell Junctions","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NR2C1"},"hgnc":{"alias_symbol":["TR2-11"],"prev_symbol":["TR2"]},"alphafold":{"accession":"P13056","domains":[{"cath_id":"3.30.50.10","chopping":"121-181","consensus_level":"high","plddt":95.6884,"start":121,"end":181},{"cath_id":"1.10.565.10","chopping":"370-595","consensus_level":"high","plddt":87.897,"start":370,"end":595}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P13056","model_url":"https://alphafold.ebi.ac.uk/files/AF-P13056-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P13056-F1-predicted_aligned_error_v6.png","plddt_mean":64.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NR2C1","jax_strain_url":"https://www.jax.org/strain/search?query=NR2C1"},"sequence":{"accession":"P13056","fasta_url":"https://rest.uniprot.org/uniprotkb/P13056.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P13056/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P13056"}},"corpus_meta":[{"pmid":"8530418","id":"PMC_8530418","title":"Multiple functions of the TR2-11 orphan receptor in modulating activation of two key cis-acting elements involved in the retinoic acid signal transduction system.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8530418","citation_count":57,"is_preprint":false},{"pmid":"9660764","id":"PMC_9660764","title":"Mechanisms of the mouse orphan nuclear receptor TR2-11-mediated gene suppression.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9660764","citation_count":23,"is_preprint":false},{"pmid":"36591938","id":"PMC_36591938","title":"NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.","date":"2023","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36591938","citation_count":22,"is_preprint":false},{"pmid":"10393558","id":"PMC_10393558","title":"Characterization of an inverted repeat with a zero spacer (IR0)-type retinoic acid response element from the mouse nuclear orphan receptor TR2-11 gene.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10393558","citation_count":22,"is_preprint":false},{"pmid":"27075724","id":"PMC_27075724","title":"Functional Divergence of the Nuclear Receptor NR2C1 as a Modulator of Pluripotentiality During Hominid Evolution.","date":"2016","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27075724","citation_count":21,"is_preprint":false},{"pmid":"28551284","id":"PMC_28551284","title":"The nuclear hormone receptor gene Nr2c1 (Tr2) is a critical regulator of early retina cell patterning.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28551284","citation_count":9,"is_preprint":false},{"pmid":"10807954","id":"PMC_10807954","title":"Characterization of the mouse nuclear orphan receptor TR2-11 gene promoter and its potential role in retinoic acid-induced P19 apoptosis.","date":"2000","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10807954","citation_count":9,"is_preprint":false},{"pmid":"26712358","id":"PMC_26712358","title":"Testicular receptor 2, Nr2c1, is associated with stem cells in the developing olfactory epithelium and other cranial sensory and skeletal structures.","date":"2015","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/26712358","citation_count":7,"is_preprint":false},{"pmid":"9503600","id":"PMC_9503600","title":"Molecular cloning from neurulating Ambystoma mexicanum embryos of the cDNA encoding an orphan nuclear receptor (aDOR1) closely related to TR2-11.","date":"1997","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/9503600","citation_count":7,"is_preprint":false},{"pmid":"9504722","id":"PMC_9504722","title":"Polymorphism in the murine Tr2-11 gene encoding an orphan receptor, and its exclusion as a candidate gene for the cataract mutation Cat3.","date":"1998","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9504722","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6777,"output_tokens":1998,"usd":0.02515,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8972,"output_tokens":2523,"usd":0.053968,"stage2_stop_reason":"end_turn"},"total_usd":0.079118,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"NR2C1 (TR2 orphan receptor) binds hormone response elements (HREs) consisting of AGGTCA half-site direct repeats with binding affinity in the order DR1 > DR2 > DR5 ≈ DR4 ≈ DR6 > DR3, and also binds palindromic TREpal and NBRE elements. It competes with RXRα and RARα/RXRα heterodimers for binding to CRBPIIp (DR1) and RARΕβ (DR5) response elements, suppressing their transcriptional activation. This suppression is not mediated by heterodimer formation with RXRα or RARα, but rather by higher affinity (≥100-fold) of NR2C1 for CRBPIIp compared to RXRα.\",\n      \"method\": \"Gel mobility shift assays for HRE binding; CAT reporter assays for transcriptional competition; binding affinity measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CAT reporter assays and gel-shift assays in single lab with two orthogonal methods\",\n      \"pmids\": [\"8530418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Mouse NR2C1 (TR2-11) functions as a transcriptional repressor via mechanisms requiring: (1) high-affinity DNA binding, (2) receptor dimerization, and (3) an active silencing domain encoded within the DEF (ligand-binding) segment. Point mutations at three conserved leucine residues on the predicted dimer interface abolish suppressive activity, dimerization, and DNA binding. Mutation of two consecutive glutamate residues in the hinge between helices 10–11 of the LBD abolishes suppressive activity and DNA binding without affecting dimerization, demonstrating that dimerization can be uncoupled from suppressive activity. The C-terminal 49 amino acids are required for trans-suppressive activity as shown by GAL4 chimera assays.\",\n      \"method\": \"CAT reporter assays, point mutagenesis of dimer interface and LBD residues, GAL4-chimera transcriptional assays, deletion analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods including mutagenesis, deletion analysis, and chimeric reporter assays defining functional domains\",\n      \"pmids\": [\"9660764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The mouse NR2C1 (TR2-11) gene promoter contains a functional IR0-type retinoic acid response element (5'-GGGTCA CGAACT-3') in its proximal promoter. RARα/RXRβ heterodimers bind specifically to this IR0 element (Kd ~8 nM) in gel retardation assays; neither receptor alone binds efficiently. This element drives RA-inducible reporter expression in COS-1 cells with exogenous RARα/RXRβ, and in P19 cells with endogenous receptors, establishing a cross-regulatory loop between NR2C1 and the RAR/RXR pathway.\",\n      \"method\": \"Gel mobility shift assays, Kd determination, CAT/reporter assays in COS-1 and P19 cells, nuclear extract binding assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution-like binding with Kd measurement plus functional reporter assays in two cell systems with orthogonal methods\",\n      \"pmids\": [\"10393558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The mouse NR2C1 (TR2-11) gene promoter minimal activity is defined within 212 nucleotides upstream of the translation start site, and efficient promoter activity requires splicing of intron 1. RARα/RXRβ binding to this minimal promoter region was demonstrated by gel retardation assays. In P19 cells, the endogenous NR2C1 gene is induced by retinoic acid in a protein synthesis-independent manner. Overexpression of NR2C1 protein in P19 cells results in cellular apoptosis in the absence of RA.\",\n      \"method\": \"Reporter/promoter-deletion assays, gel retardation assays, protein synthesis inhibition (cycloheximide) experiments, overexpression in P19 cells with apoptosis readout\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple assays in single lab including gel retardation, reporter assays, and functional overexpression with apoptosis phenotype\",\n      \"pmids\": [\"10807954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NR2C1 modulates transcriptional activity of pluripotency regulators Oct4 and Nanog, and affects promoter activity of Pepck (a differentiation proxy) and embryonic stem cell colony size (self-renewal proxy). Human, chimpanzee, and ancestral NR2C1 variants show functional differences in these assays, indicating that amino acid changes in NR2C1 during hominid evolution altered its ability to regulate pluripotency and cell lineage commitment.\",\n      \"method\": \"Luciferase reporter assays for Oct4, Nanog, and Pepck promoters; embryonic stem cell colony size assays; comparison of human, chimpanzee, and ancestral NR2C1 variants\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays and stem cell colony assays with multiple NR2C1 variants in single study\",\n      \"pmids\": [\"27075724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nr2c1 (Tr2) is required for early retinal cell patterning; loss of Nr2c1 causes severe vision deficit and disrupts early (but not late) retinal cell types, with increased displaced amacrine cells and disrupted cone cell topography. ChIP experiments reveal NR2C1 directly binds regulatory regions of transcription factors controlling retinal progenitor cells, including Satb2 (amacrine regulator) and thyroid and retinoic acid receptors (cone photoreceptor regulators).\",\n      \"method\": \"Nr2c1 knockout mouse (loss-of-function), histological and cell-type analysis, chromatin immunoprecipitation (ChIP) assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with specific cellular phenotype plus ChIP establishing direct chromatin binding to target gene regulators\",\n      \"pmids\": [\"28551284\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NR2C1 (TR2/TR2-11) is an orphan nuclear receptor that functions primarily as a transcriptional repressor by binding DR-type hormone response elements as a homodimer, competing with RAR/RXR heterodimers for DNA occupancy, and silencing target genes through an active repression domain in its ligand-binding region (DEF segment); it is itself transcriptionally induced by retinoic acid via an IR0-type RARE in its promoter bound by RARα/RXRβ heterodimers, participates in regulating stem cell pluripotency (Oct4/Nanog), and is required in vivo for early retinal cell fate determination by directly binding chromatin at genes controlling progenitor cell identity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NR2C1 (TR2/TR2-11) is an orphan nuclear receptor that acts as a sequence-specific transcriptional repressor controlling cell fate decisions and the retinoid signaling axis [#0, #5]. It binds AGGTCA half-site direct-repeat hormone response elements with a preference order of DR1 > DR2 > DR5 ≈ DR4 ≈ DR6 > DR3, as well as palindromic TREpal and NBRE elements, and it antagonizes RXRα and RARα/RXRα by outcompeting them for shared elements such as CRBPIIp (DR1) and RARβ (DR5) — a competition driven by NR2C1's ≥100-fold higher DNA affinity rather than by heterodimerization [#0]. Repression requires three separable activities: high-affinity DNA binding, receptor dimerization through a leucine-dependent dimer interface, and an active silencing domain within the C-terminal DEF (ligand-binding) region, whose terminal 49 residues confer trans-suppression in GAL4 chimeras [#1]. NR2C1 is itself embedded in a cross-regulatory loop with the retinoid pathway: its proximal promoter contains an IR0-type RARE bound by RARα/RXRβ heterodimers (Kd ~8 nM), rendering the gene retinoic-acid-inducible in a protein-synthesis-independent manner [#2, #3]. Functionally, NR2C1 modulates the pluripotency regulators Oct4 and Nanog and influences embryonic stem cell self-renewal and lineage commitment [#4], and it is required in vivo for early retinal cell patterning, binding chromatin at regulators of progenitor identity including Satb2 and thyroid/retinoic acid receptors, with its loss causing vision deficits and disrupted amacrine and cone cell organization [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that NR2C1 is a DNA-binding orphan receptor that represses retinoid target genes not by heterodimerizing with RXR/RAR but by directly outcompeting them at shared response elements.\",\n      \"evidence\": \"Gel mobility shift and CAT reporter competition assays with affinity measurements on CRBPIIp and RARβ elements\",\n      \"pmids\": [\"8530418\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Repression mechanism downstream of DNA occupancy not defined\", \"No cofactor or chromatin-modifying partner identified\", \"Endogenous target genes not yet mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Dissected the repression machinery into separable modules, showing dimerization can be uncoupled from suppression and localizing an active silencing domain to the C-terminal DEF region.\",\n      \"evidence\": \"Point mutagenesis of dimer-interface leucines and LBD glutamates, deletion analysis, and GAL4-chimera assays\",\n      \"pmids\": [\"9660764\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Corepressor proteins recruited by the silencing domain not identified\", \"No structural model of the dimer interface or LBD\", \"Ligand, if any, for the orphan LBD unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined a feedback loop placing NR2C1 downstream of retinoid signaling via an IR0-type RARE in its own promoter bound by RARα/RXRβ.\",\n      \"evidence\": \"Gel retardation with Kd determination and reporter assays in COS-1 and P19 cells\",\n      \"pmids\": [\"10393558\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Physiological significance of the autoregulatory loop in vivo not tested\", \"Other promoter inputs not characterized\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Refined the minimal promoter and showed RA induction is protein-synthesis-independent, while implicating NR2C1 in cell survival when overexpressed.\",\n      \"evidence\": \"Promoter-deletion reporter assays, cycloheximide experiments, and overexpression with apoptosis readout in P19 cells\",\n      \"pmids\": [\"10807954\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism linking NR2C1 overexpression to apoptosis unresolved\", \"Requirement for intron 1 splicing mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked NR2C1 to control of pluripotency and lineage commitment, and showed hominid sequence changes altered its regulatory output.\",\n      \"evidence\": \"Luciferase reporter assays on Oct4, Nanog, and Pepck promoters and ES cell colony assays comparing human, chimpanzee, and ancestral variants\",\n      \"pmids\": [\"27075724\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct chromatin binding at Oct4/Nanog loci not demonstrated\", \"In vivo developmental consequence of variant differences untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated an in vivo developmental requirement, with NR2C1 directly binding regulators of retinal progenitor identity to control early cell-fate patterning.\",\n      \"evidence\": \"Nr2c1 knockout mouse with histological cell-type analysis and ChIP at Satb2 and thyroid/retinoic acid receptor loci\",\n      \"pmids\": [\"28551284\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether NR2C1 activates or represses each retinal target not resolved\", \"Cofactors mediating retinal target regulation unknown\", \"Genome-wide binding landscape not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether NR2C1 has an endogenous ligand and which corepressor complexes execute its DEF-domain silencing remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No ligand identified for the orphan LBD\", \"Corepressor/chromatin-modifier partners of the silencing domain not identified\", \"No structural data on DNA-bound NR2C1\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RARA\", \"RXRB\", \"RXRA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}